We have cloned a 4.5 kb EcoRI/BamHI DNA fragment from Bordetella pertussis which contains at least two genes responsible for expression of pertussis toxin. The S4 subunlt of the toxin was isolated by high pressure liquid chromatography and the NH_-tenninal amino acid sequence determined. Using a mixed synthetic oligonucleotide probe designed by reverse translation of a portion of the protein sequence, a cloned DNA fragment was identified which contains the coding information for at least the S4 structural subunit of the toxin. Sequence analyses indicate that the mature protein is derived by proteolytic cleavage of a precursor molecule. Southern blot analyses of Tn5-induced 15. pertussis toxin-deficient mutants show that the Tn5 DNA is inserted 1.3 kb downstream from the S4 subunit gene. This second gene could code for another subunit required for assembly of the mature toxin or a non-structural transport protein, possibly in the same polycistronic operon. The molecular cloning of pertussis toxin genes provides the basis for development of a safer recombinant "new generation" vaccine for whooping cough.
INTRODUCTION
Development of a safer, "new generation" vaccine for whooping cough can be accomplished by molecular cloning and genetic manipulation of the genomic DNA of J5. pertussis, the microorganism responsible for the disease. One important antigenic component of the current vaccine is pertussis toxin, also known as lymphocytosis promotion factor, histamine-sensitlzing factor, Islet-activating protein, and pertussigen (1) . It Is one of several toxins produced by virulent 15 . pertussis (2) . While this toxin is one of the major protective antigens against whooping cough, as shown by intracerebral (3, 4) or aerosol (4) challenge in mice, and is used in the component vaccine in Japan (5) it is also associated with a variety of pathophysiological activities and has been suggested to be the major cause of the harmful side effects associated with the present pertussis vaccine. In most recipients these effects are limited to local reactions, but regrettably, in rare cases neurological damage and sometimes death occurs (see ref. 6 for review and references).
Pertussis toxin is a globular complex protein composed of five different subunits. The 117,000 molecular weight native toxin can be separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) into individual subunits with molecular weights of 28 kD (SI), 23 kD (S2) , 22 kD (S3), U.7 kD (S4), and 9.3 kD (S5) (see Fig. 1 ); the molar ratio of the subunits is 1:1:1:2:1, respectively (7) . By analogy to diphtheria toxin, Pseudomonas toxin, cholera toxin, and Escherlchia coli heat-labile toxin, pertussis toxin is structured in an A-B model (8) . In this model, the A-moiety (SI in pertussis toxin) contains an enzymatic activity responsible for the ADP-ribosylation (9) of specific regulatory proteins. The B-moiety (S2 through S5 in pertussis toxin) is responsible for attachment of the toxin to the host cell membrane and internalization of the A-protomer into the target cell (10) . Once inside the host cell, SI (dissociated from the B-oligomer) catalyzes the transfer of the ADP-ribosyl moiety of NAD to the membrane bound guanyl nucleotide-binding regulatory protein (NJ or Gi) of the adenylate cyclase complex (11, 12) . This covalent modification of Ni results in an uncoupling of Ni from inhibition receptors. Thus, activation of the adenylate cyclase catalytic subunit by stimulatory receptors cannot be reversed by inhibitors, which subsequently results in an increase of intracellular cAMP (13) . This increase in cAMP may be the cause of many of the biological effects associated with pertussis toxin.
Progress in the development of a cloned subunit vaccine has been hampered by the inherent difficulties in identifying DNA fragments containing specific genes which code for protective antigens. The polycistronic gene arrangement of procaryote cells, similarities with other bacterial toxins (14) (15) (16) (17) (18) (19) (20) , and preliminary mutagenic experiments by other investigators (21) suggest that the genes coding for the protein subunits of pertussis toxin may be linked in a tandem arrangement regulated by one operator. Thus, isolation of a DNA fragment containing one subunit gene could quickly lead to the isolation and characterization of all the genes responsible for pertussis toxin. Recent pertussis DNA studies in our laboratory using recombinant expression vectors and pertussis toxin antibodies suggest that cloning strategies which rely on expression of protein in an £. coli host have not been successful, probably because of differences in the signals that regulate gene transcription. A more direct approach using synthetic oligonucleotide probes which code for specific portions of antigenic proteins has proven to be more effective in identifying cloned DNA fragments of interest. We describe here the molecular cloning of pertussis toxin genes in £. coli, a first step in the development of a safer pertussis vaccine.
MATERIALS AND METHODS
._ Purification of Pertussis Toxin Subunits.
s-__
Pertussis toxin from strain 3779 was prepared as previously described (22) . Five mg of the toxin was resuspended in trifluoroacetic acid and
• fractionated by HPLC using a 1 X 25 cm Vydac C-4 preparative column. Thê sample was injected in 50% trifluoroacetic acid and eluted at 4 ml/min over 30 min with a linear gradient of 25% to 100% acetonitrile solution containing 66% acetonitrile and 33% isopropyl alcohol. All solutions contained 0.1% '* trifluoroacetic acid. Elution was monitored at 220 nm and two ml fractions collected. Aliquots of selected fractions were dried by evaporation, resuspended in gel loading buffer containing 2-mercaptoethanol and analyzed by SDS-PAGE on a 12% gel.
v Protein and DNA Sequencing.
The polypeptide from HPLC fraction 21 (see Fig. 1 , lane 4) was sequenced using a Beckman 890C automated protein sequenator. The methods have been described previously (23) . DNA was sequenced from the Smal site (see Fig. 2b) by the Maxam and Gilbert technique (24) .
Isolation of Pertussis Toxin Genes.
Chromosomal DNA was prepared from 15. pertussis strain 3779 as previously described (25) . The DNA was digested with both endonucleases EcoRI and BamHI « and ligated into the same sites in the polylinker of pMC1403 (26, 27) . The conditions for ligation were: 60 ng of vector DNA and 40 ng of insert DNA incubated with 1.5 units of T, DNA ligase (BRL) and 1 mM ATP at 15°C for 20 h.
E. coli JM109 cells were transformed with the recombinant plasmid (28) and clones containing the toxin gene identified by colony hybridization at 37°C
(29) using a P-labeled 17-base mixed oligonucleotide probe 21D3. The probe was synthesized on a SAM-1 DNA synthesizer (Biosearch, San Rafael, California) and consisted of the 32 possible oligonucleotides coding for 6 consecutive amino acids of the pertussis toxin subunit (see Table 1 ). The probe was purified from a 20% urea-acrylaoide gel and 5'-end labeled using 0.2 mCi of Southern Blot Analyses.
DNA was extracted as previously described (25) . Digested DNA was separated by electrophoresis using either 0.7% or 1.2% agarose gels in 40 mM
Tris-acetate pH 8.3, 1 mM EDTA for 17 h at 30 V. The DNA was then blotted onto nitrocellulose in 20X SSPE (27) and baked at 80°C in a vacuum oven for 2 h. were hybridized at a concentration of about 1 yCi/ml for 48 h at 68°C. Filters were then washed in 2X SSPE and 0.5% SDS at room temperature for 5 min, then in 2X SSPE and 0.1% SDS at room temperature for 15 min, and finally in 0.1X SSPE and 0.5% SDS at 68"C for 2 h. The washed filters were air dried and exposed to X-ray film using a Lightning-Plus intensifying screen.
RESULTS AND DISCUSSION
Isolation and cloning of S4 subunlt gene.
Purified pertussis toxin (22) on SDS-PAGE (Fig. 1, lane 4) . Although complete separation was not achieved, the major portion of the other toxin subunits were recovered in other HPLC fractions, i.e., S2 in Fr22, SI and S5 in Fr23, and S3 in Fr24 (Fig. 1) sequenced using the Maxam and Gilbert technique (24) . The DNA sequence was translated into an amino acid sequence and a portion of that sequence is compared in Table 1 to the NH.-terminal 30 amino acids of the pertussis toxin subunit and the oligonucleotide probe 21D3 sequence. Out of the sequence of 30 amino acid residues determined using the automated sequenator, only 2 do not correspond to the amino acid sequence deduced from the DNA sequence, i.e., residues 24 and 26 are questionable because they repeat the amino acid in front of them and they are located near the end of the analyzed sequence. Amino acid 15 could not be determined. The rest of the deduced amino acid sequence perfectly matches the original protein sequence. The oligonucleotide probe sequence also perfectly matches the cloned DNA sequence. These results indicate that we have cloned at least one of the pertussis toxin subunit genes.
Examination of the DNA sequence indicates that a precursor protein, perhaps containing a leader sequence, may exist (Table 1 ). In fact, the NH.-terminal aspartic acid of the mature protein is not immediately preceded by one of the known initiation codons, i.e., ATG, GTG, TTG, or ATT (30), but by GCC coding for alanine, an amino acid that often occurs at the cleavage site of a signal peptide (31) (32) (33) . A proline is found at amino acid position -4, which is also consistent with cleavage sites in other known sequences where this amino acid is usually present within six residues of the cleavage site. protein and upstream of the NH.-terminal aspartic acid are: ATG at position -9, TTG at -15, and GTG at -21; however, none of these are preceded by a Shine/Dalgarno ribosomal binding site (34) and only GTG at -21 is immediately followed by a basic amino acid (arginine) preceding a hydrophobic region, characteristic of bacterial signal sequences (35, 36) . The unusual GTG translation initiation codon is used in the diphtheria toxin gene (14) . Using the DNA sequence data and primer extension to sequence the mRNA we may be able to determine the actual initiation site.
Physical mapping of the S4 gene on the bacterial chromosome.
We then used the 1.3 kb PstI fragment B containing at least part of the pertussis toxin gene as a probe to physically map the location of this gene on the J3. pertussis genome (see Fig. 2 ). However, when the PstI fragment C was used as a probe, the genomic DNA from mutant strains BP356 and BP357 showed a clear difference in the size of the PstI fragments that hybridized as compared to strain 3779 and the other mutant strains (Fig. 3c, lanes 6 and 7) . These results indicate that this fragment contains the site of the Tn5 insertion. As expected, two labeled fragments were found, since the Tn5 DNA insert has two symmetrical PstI sites. Other
Southern blots (not shown) in which genomic Bglll and Smal fragments were hybridized with the 4.5 kb EcoRI/BamHI cloned probe, and the data from Figure   3c , clearly show that the Tn5 DNA was inserted 1.3 kb downstream from the start of the mature pertussis toxin S4 subunit in the two mutant strains that were characterized as pertussis toxin negative phenotypes, i.e., BP356 and BP357 (see Fig. 2b ). This insertion is beyond the termination codon for the S4 subunit (11.7 kD). Examination of these toxin negative mutants by Western blots using monoclonal antibodies for individual subunits indicate that the Tn5 coli heat labile toxin (15) (16) (17) (18) and cholera toxin (16) (17) (18) (19) (20) . Further characterization and DNA sequence data is needed to understand more about the expression, regulation of expression and the gene structure of pertussis toxin.
The molecular cloning of the pertussis toxin gene opens the possibility of investigating some of these basic questions and developing a safer vaccine through genetic engineering.
